Biogen

American multinational biotechnology company

BIIB Nasdaq ISIN US09062X1037 SEC CIK 875045 LEI W8J5WZB5IY3K0NDQT671
Follow Biogen Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $2.8B +10.6% vs same quarter last year
Net income −$20.6M −104.4% vs same quarter last year
EPS, diluted −$0.14 −104.4% vs same quarter last year
Operating cash flow $640.8M −49.6% vs same quarter last year
Revenue by quarter
$2.5B
$2.4B
$2.6B
$2.5B
$2.3B
$2.5B
$2.7B
$2.8B
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
$0$5B$10B$15BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$9.9B$1.3B
FY24$9.7B$1.6B
FY23$9.8B$1.2B
FY22$10.2B$3B
FY21$11B$1.6B
FY20$13.4B$4B
FY19$14.4B$5.9B
FY18$13.5B$4.4B
FY17$12.3B$2.5B
FY16$11.4B$3.7B
FY15$10.8B$3.5B
FY14$9.7B$2.9B
FY13$6.9B$1.9B
FY12$5.5B$1.4B
FY11$5B$1.2B
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
0%25%50%75%100%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2575.7%-13.1%
FY2476.1%-16.9%
FY2374.2%-11.8%
FY2277.6%-30%
FY2180.8%25.9%14.2%
FY2086.6%33.8%29.8%
FY1986.4%49%41%
FY1886.5%43.8%32.9%
FY1786.7%43.6%20.7%
FY1687.1%45%32.3%
FY1588.5%45.4%33%
FY1487.9%40.9%30.2%
FY1387.6%36.3%26.9%
FY1290.1%33.6%25%
FY1190.8%34.2%24.5%
Free cash flowOperating cash flow minus capital expenditure
$0$2B$4B$6B$8BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$2.1B
FY24$2.7B
FY23$1.3B
FY22$1.1B
FY21$3.4B
FY20$3.8B
FY19$6.6B
FY18$5.4B
FY17$3.7B
FY16$4B
FY15$3.3B
FY14$2.7B
FY13$2.1B
FY12$1.6B
FY11$1.5B
Returned to shareholdersDividends paid and shares bought back
$0$2B$4B$6B$8BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearBuybacks
FY25-
FY24$0
FY23$0
FY22$750M
FY21$1.8B
FY20$6.7B
FY19$5.9B
FY18$4.4B
FY17$1.4B
FY16$1B
FY15$5B
FY14$886.8M
FY13$400.3M
FY12$984.7M
FY11$498M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Biogen
  • Healthcare median
−100%−50%0%50%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearBiogenHealthcare median
FY2513.1%−30.6%
FY2416.9%−47%
FY2311.8%−58%
FY2230%−80.4%
FY2114.2%−71.9%
FY2029.8%−62.2%
FY1941%−46.3%
FY1832.9%−49.6%
FY1720.7%−45.9%
FY1632.3%−36%
FY1533%−38.4%
FY1430.2%−35.5%
FY1326.9%−37.1%
FY1225%−29.1%
FY1124.5%−27.9%